InsidersTradesSigma
Browse the detailed record of transactions filed by Rosol Michael Stanley, Directeur Médical. Director active across 1 company, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 2 reports have been published. Activity tracked since 14 January 2022. The latest transaction was filed on 14 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Rosol Michael Stanley is the Chief Medical Officer at NAVIDEA BIOPHARMACEUTICALS, INC. He oversees the company's medical and research initiatives, ensuring that projects meet the highest standards. His expertise is crucial for the development of new therapies.